
LOGIN / SKAPA KONTO
Aktuellt
SUMMARY Do patients with greater knowledge manage their disease better? This question was addressed in a cross sectional study presented at ERS2025....
This was the resounding message from a recent international panel moderated by Dr. Liz Steve, a UK-based health psychologist, at the ERS...
In modern care, patients are expected to be empowered and to actively participate in decision making regarding their own healthcare. And on...
A preview of new insights into COPD and comorbidities Global leading researchers —strongly represented by the Nordics—presented compelling findings on chronic obstructive...
SUMMARY Why we still need to address inhalation technique. Effective inhaler therapy hinges on matching the right device to the right patient—and...
SUMMARY Are eosinophils in COPD truly a marker of type 2 (T2) inflammation, or do they simply reflect underlying or misclassified asthma?...
SUMMARY Some get off to a bad start, others simply do not realize they have a disease. And others fall into the...
SUMMARY Many preventable respiratory hazards are both a cause and a consequence of climate change. Fine particulate matter, especially from wildfires and...
SUMMARY Lifelong exposure to environmental factors — especially air pollution — significantly affects the risk and progression of chronic lung diseases, and...
Clinical remission in adults with moderate-to-severe asthma A new framework from Professor Celeste Porsbjerg’s team redefines remission in severe asthma by focusing...
SUMMARY Women are more affected by asthma in adulthood and increasingly by COPD. Sex hormones influence immune responses in asthma, with estrogen...
Chiesi er et familieeid legemiddelselskap grunnlagt i 1935. Vi tror på innovasjon, ansvar og menneskelig empati. Vår lidenskap er å forbedre livskvaliteten for pasienter over hele verden gjennom forskning, utvikling og bærekraftige løsninger.
© 2026 Chiesi Pharma AB. Dette nettstedet er beregnet på helsepersonell i Norge.









